Antifungal Drug Improves Cystic Fibrosis Biomarkers
A drug used to treat fungal infections improved key biomarkers in lung tissue cultures of patients with cystic fibrosis.
A drug used to treat fungal infections improved key biomarkers in lung tissue cultures of patients with cystic fibrosis.
Researchers at the University of Michigan have created a 3D bioengineered model of lung tissue to better understand cystic fibrosis and potential treatments.
In a recent study, researchers at the Seoul National University College of Medicine found a possible protective role for bronchiectasis against lung cancer.
Researchers at the University of Virginia School of Engineering and other across the country are working on a computer model to understand which genes cause cystic fibrosis and other diseases.
Read MoreSwiss researchers highlight how the protein Vav3 creates bacterial docking stations to facilitate lung infections in cystic fibrosis.
Read MoreResearch from a study in Respiratory Medicine found that patients with cystic fibrosis (CF) may have a lower rate of the novel coronavirus compared to the general population.
Read MoreVertex Pharmaceutical’s triple combination cystic fibrosis treatment, Kaftrio, is one step closer to coming to market after receiving a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).
Read MoreNew research uncovered that tobacco smoke can inhibit the therapeutic benefit of the cystic fibrosis transmembrane conductance regulator (CFTR) modulators in children.
Read MoreOn June 27 the Ohio Cobra Club will raffle a replica Shelby 427 Cobra to raise funding for research at the Cystic Fibrosis Foundation.
Read MoreNew York State’s Adult Cystic Fibrosis Assistance Program (ACFAP) was defunded and will no longer be reimbursing CF patients for medical expenses.
Read MoreThe Cystic Fibrosis Foundation is supporting the development of Synspira’s SNSP003, an orally-delivered non-porcine enzyme replacement therapy (ERT) designed to treat malabsorption syndromes.
Read MoreA new treatment that combines three antibiotics safely eradicated Mycobacterium abscessus (M. abscessus) bacteria extracted from cystic fibrosis lungs.
Read MoreCystic fibrosis patients being treated with a CFTR modulator had more positive outlooks on their futures, treatment plans, and healthcare professionals.
Read MoreA phase three clinical trial that UT Southwestern participated in determined that a three-drug...
Read MoreChronic lung conditions such as asthma require aerosolized pharmacological maintenance therapy, but data suggests the frequency and dosages can often be overprescribed and based on empirical assumptions rather than clinical evidence.
Read More